MedTrace Logo

Relationship Between Circulating Sclerostin and Bone Lesions in Patients With Mastocytosis

NCT06440148 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-06-03

No results posted yet for this study

Summary

Mastocytosis is very rare and highly heterogeneous group of disorders, characterized by the accumulation of clonal mast cells which can infiltrate several organs and tissues.

Bones are the most frequent localization of systemic mastocytosis. The aim of our research was to explain the potential role of sclerostin in the pathogenesis of bone disease in mastocytosis.

Conditions

  • Mastocytosis
  • Bones

Interventions

BIOLOGICAL

SCLEROSTIN

Pathogenesis of mastocytosis bone disease

Sponsors & Collaborators

  • Medical University of Lublin

    lead OTHER

Principal Investigators

  • Aneta A Szudy-Szczyrek, MD., PhD. · Medical University of Lublin

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2024-05-01
Completion
2026-12-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06440148 on ClinicalTrials.gov